Baseler MW - Search Results

1

Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck.

Veltri RW, Rodman SM, Maxim PE, Baseler MW, Sprinkle PM. Veltri RW, et al. Among authors: baseler mw. Cancer. 1986 Jun 15;57(12):2295-308. doi: 10.1002/1097-0142(19860615)57:12<2295::aid-cncr2820571211>3.0.co;2-q. Cancer. 1986. PMID: 3084060

2

Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer.

Baseler MW, Maxim PE, Veltri RW. Baseler MW, et al. Cancer. 1987 May 15;59(10):1727-31. doi: 10.1002/1097-0142(19870515)59:10<1727::aid-cncr2820591009>3.0.co;2-n. Cancer. 1987. PMID: 3828945

3

A new class of synthetic biological response modifiers: the methylfurylbutyrolactones (Nafocare B).

Veltri RW, Fodor G, Liu CM, Woolverton CJ, Baseler MW. Veltri RW, et al. Among authors: baseler mw. J Biol Response Mod. 1986 Oct;5(5):444-61. J Biol Response Mod. 1986. PMID: 3021912

4

Immunological monitoring and clinical trials of biological response modifiers.

Urba WJ, Baseler MW. Urba WJ, et al. Among authors: baseler mw. Cancer Chemother Biol Response Modif. 1988;10:473-91. Cancer Chemother Biol Response Modif. 1988. PMID: 2484322 Review. No abstract available.

5

Immunological monitoring and clinical trials of biological response modifiers.

Baseler MW, Urba WJ. Baseler MW, et al. Cancer Chemother Biol Response Modif. 1991;12:231-50. Cancer Chemother Biol Response Modif. 1991. PMID: 1931445 Review. No abstract available.

6

Immunological monitoring and clinical trials of biological response modifiers.

Urba WJ, Baseler MW. Urba WJ, et al. Among authors: baseler mw. Cancer Chemother Biol Response Modif. 1990;11:281-302. Cancer Chemother Biol Response Modif. 1990. PMID: 2121208 Review. No abstract available.

7

Immunological monitoring and clinical trials of biological response modifiers.

Baseler MW, Urba WJ. Baseler MW, et al. Cancer Chemother Biol Response Modif. 1992;13:205-29. Cancer Chemother Biol Response Modif. 1992. PMID: 1382527 Review. No abstract available.

8

Immunological monitoring and clinical trials of biological response modifiers.

Baseler MW, Kopp WC, Urba WJ. Baseler MW, et al. Cancer Chemother Biol Response Modif. 1993;14:249-83. Cancer Chemother Biol Response Modif. 1993. PMID: 7508729 Review. No abstract available.

9

Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.

Urba WJ, Baseler MW, Kopp WC, Steis RG, Clark JW, Smith JW 2nd, Coggin DL, Longo DL. Urba WJ, et al. Among authors: baseler mw. Blood. 1989 Jan;73(1):38-46. Blood. 1989. PMID: 2783373 Free article.

10

Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.

Derby EG, Reddy V, Nelson EL, Kopp WC, Baseler MW, Dawson JR, Malyguine AM. Derby EG, et al. Among authors: baseler mw. Cytokine. 2001 Jan 21;13(2):85-90. doi: 10.1006/cyto.2000.0804. Cytokine. 2001. PMID: 11145847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results